Elevated levels of cytokines associated with Th2 and Th17 cells in vitreous fluid of proliferative diabetic retinopathy patients

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Takeuchi, Masaru ^a   Sato, Tomohito ^a   Tanaka, Atsushi ^a   Muraoka, Tadashi ^a   Taguchi, Manzo ^a   Sakurai, Yutaka ^a   Karasawa, Yoko ^a   Ito, Masataka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EPIRETINAL MEMBRANE; FEMALE; HELPER CELL; HUMAN; IMMUNE RESPONSE; LASER COAGULATION; MALE; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SARCOIDOSIS; TH17 CELL; TH2 CELL; UVEITIS; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE; BLOOD; DIABETIC RETINOPATHY; EYE; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA TEAR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; DIABETIC RETINOPATHY; EYE; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MALE; MIDDLE AGED; RETINAL PERFORATIONS; SARCOIDOSIS; TH17 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VITRECTOMY; VITREOUS BODY;

EID: 84944754760     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137358     Document Type: Article

References (29)

1. Kempen JH, O'Colmain BJ, LeskeMC, HaffnerSM, Klein R, Moss SE, et al. The Prevalence of Diabetic Retinopathy among Adults in the United States. Arch Ophthalmol. 2004;122(4):552-63. PMID: 15078674
2. Gologorsky D, Thanos A, Vavvas D. Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators Inflamm. 2012;2012:629452. doi: 10.1155/2012/629452 Epub 2012 Sep. 17. PMID: 23028203
3. Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30(5):343-58. doi: http://dx.doi.org/10.1016/j.preteyeres.2011.05.002. doi: 10.1016/j.preteyeres.2011.05.002 PMID: 21635964
4. Demircan N, Safran BG, Soylu M, Ozcan AA, SizmazS. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye. 2006;20(12):1366-9. Epub 2005/11/15. doi: 10.1038/sj.eye.6702138 PMID: 16284605.
5. Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina. 2008;28(6):817-24. doi: 10.1097/IAE. 0b013e31816576d5 PMID: 18536597
6. Nawaz MI, Van Raemdonck K, Mohammad G, Kangave D, Van Damme J, Abu El-Asrar AM, et al. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy. Exp Eye Res. 2013;109:67-76. doi: 10.1016/j.exer.2013.01.008 Epub Jan 22. PMID: 23352833
7. Canataroglu H, Varinli I, Ozcan AA, Canataroglu A, Doran F, Varinli S. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocul Immunol Inflamm. 2005;13(5):375-81. PMID: 16422002
8. Kakehashi A, InodaS, MameudaC, Kuroki M, JonoT, Nagai R, et al. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy. Diabetes Res Clin Pract. 2008;79(3):438-45. Epub 2007 Nov. 28. PMID: 18053608
9. Cantón A, Martinez-Cáceres EM, Hernández C, Espejo C, García-Arumí J, Simó R. CD4-CD8 and CD28 expression in t cells infiltrating the vitreous fluidin patients with proliferative diabetic retinopathy: A flow cytometric analysis. Arch Ophthalmol. 2004;122(5):743-9. doi: 10.1001/archopht.122.5.743 PMID: 15136323
10. UrbancicM, Kloboves PrevodnikV, PetrovicD, Globocnik Petrovic M. A flow cytometric analysis of vitreous inflammatory cells in patients with proliferative diabetic retinopathy. Biomed Res Int. 2013;2013:251528. doi: 10.1155/2013/251528 Epub 2013 Oct. 27. PMID: 24282811
11. Stott B, Lavender P, Lehmann S, Pennino D, Durham S, Schmidt-Weber CB. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol. 2013;132(2):446-54.e5. doi: 10.1016/j.jaci.2013.03.050 Epub May 18. PMID: 23694808
12. MaddurMS, Miossec P, Kaveri SV, Bayry J. Th17cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181(1):8-18. doi: 10.1016/j. ajpath.2012.03.044 PMID: 22640807.
13. Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013:968549. doi: 10.1155/2013/968549 Epub2013 Jul. 14. PMID: 23956763
14. Smith E, Prasad K-MR, Butcher M, Dobrian A, Kolls JK, Ley K, et al. Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation. 2010;121(15):1746-55. doi: 10.1161/CIRCULATIONAHA.109.924886 PMID: 20368519
15. Zúñiga LA, Shen W-J, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thom C, et al. IL-17 Regulates Adi-pogenesis, Glucose Homeostasis, and Obesity. J Immunol. 2010;185(11):6947-59. doi: 10.4049/jimmunol.1001269 PMID: 21037091
16. Schuerwegh AJ, DeClerckLS, BridtsCH, Stevens WJ. Comparison of intracellular cytokine production with extracellular cytokine levels using two flow cytometric techniques. Cytometry B Clin Cytom. 2003;55(1):52-8. doi: 10.1002/cyto.b.10041 PMID: 12949960.
17. Adamiec-Mroczek J, Oficjalska-Mtyhczak J, Misiuk-Hojto M. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples. Cytokine. 2010;49(3):269-74. doi: http://dx.doi.org/10.1016/j.cyto.2009.11.004. doi: 10.1016/j. cyto.2009.11.004 PMID: 20015663
18. Zhou J, Wang S, XiaX. Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy. Curr Eye Res. 2012;37(5):416-20. doi: 10.3109/02713683.2012.661114 PMID: 22409294
19. Suzuki Y, NakazawaM, Suzuki K, Yamazaki H, MiyagawaY. Expression profiles of cytokines and che-mokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol. 2011;55(3):256-63. Epub 2011/05/04. doi: 10.1007/s10384-011-0004-8 PMID: 21538000.
20. Schoenberger SD, Kim SJ, Sheng J, Rezaei KA, Lalezary M, Cherney E. Increased Prostaglandin E2 (PGE2) Levels in Proliferative Diabetic Retinopathy, and Correlation with VEGF and Inflammatory Cytokines. Invest Ophthalmol Vis Sci. 2012;53(9):5906-11. doi: 10.1167/iovs.12-10410 PMID: 22871833
21. Aggarwal S, GurneyAL. IL-17: prototype member of an emerging cytokine family. J LeukocBiol. 2002;71(1):1-8. PMID: 11781375
22. Tzartos JS, Friese MA, CranerMJ, Palace J, Newcombe J, Esiri MM, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol. 2008;172(1):146-55. Epub 2007 Dec. 21. PMID: 18156204
23. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2and inhibited by IL-27/STAT1. Nat Med. 2007;13(6):711-8. Epub 2007 May 13. PMID: 17496900
24. Bromberg-White JL, Glazer L, Downer R, Furge K, Boguslawski E, Duesbery NS. Identification of VEGF-Independent Cytokines in Proliferative Diabetic Retinopathy Vitreous. Invest Ophthalmol Vis Sci. 2013;54(10):6472-80. doi: 10.1167/iovs.13-12518 PMID: 24003089
25. Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, et al. Vitreous Mediators after Intravitreal Bevacizumab or Triamcinolone Acetonide in Eyes with Proliferative Diabetic Retinopathy. Ophthalmology. 2009;116(5):921-6. doi: http://dx.doi.org/10.1016/j.ophtha.2008.12.024. doi: 10.1016/j. ophtha.2008.12.024 PMID: 19410951
26. Dillon SR, SprecherC, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleu-kin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752-60. doi: http://www.nature.com/ni/journal/v5/n7/suppinfo/ni1084 S1.html. PMID: 15184896
27. Neis MM, Peters B, DreuwA, Wenzel J, BieberT, MauchC, et al. Enhanced expression levels of IL-31 correlate with IL-4and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 2006;118(4):930-7. Epub 2006 Sep. 1. PMID: 17030248
28. DambacherJ, Beigel F, SeidererJ, Haller D, Goke B, AuernhammerCJ, et al. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut. 2007;56(9):1257-65. Epub 2007 Apr. 20. PMID: 17449633
29. LeiZ, Liu G, Huang Q, LvM, Zu R, Zhang GM, et al. SCFand IL-31 rather than IL-17 and BAFFare potential indicators in patients with allergic asthma. Allergy. 2008;63(3):327-32. Epub 2007 Dec. 5. PMID: 18053009